All blog posts
Total 2 results for
Showing 2 out of 2 results
23 November 2022
Sanction imposed by the Spanish competition authority for misusing litigation strategies regarding patents
11 October 2022
Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor
Showing 2 out of 2 results
Key contacts
Laura Orlando
Italy Managing Partner, Joint Global Head of Intellectual Property, EMEA Co-Head of Life Sciences, Milan
